Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Diabetes. Dec 15, 2013; 4(6): 295-302
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.295
Figure 1
Figure 1 Intravitreal triamcinolone acetonide injection. A: External aspect demonstrating intravitreal triamcinolone acetonide (IVTA) injection through the inferior pars plana in sterile conditions; B: Vitreous cavity aspect demonstrating IVTA injection with inferior deposition of triamcinolone acetonide crystals over the retinal surface on a patient with diabetic macular edema refractory to laser photocoagulation.
Figure 2
Figure 2 Diabetic macular edema before and after intravitreal triamcinolone acetonide injection.
Figure 3
Figure 3 Ozurdex biodegradable dexamethasone injectable intravitreal implant in a patient with non-proliferative diabetic retinopathy, diabetic macular edema, and supero-temporal branch retinal vein occlusion.